REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

09995 REMEGEN

Market Closed 04-24 16:08:27

104.200

-0.500

-0.48%

High106.600	Low100.800	Vol2.93M
Open105.300	D1 Closing104.700	Amplitude5.54%
Mkt Cap58.73B	Tradable Cap21.73B	Total Shares563.61M
T/O304.22M	T/O Rate1.41%	Tradable Shares208.58M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"REMEGEN","latestPrice":104.2,"timestamp":1777018107011,"preClose":104.7,"halted":0,"volume":2933200,"delay":0,"changeRate":-0.004775549188156638,"floatShares":208581239,"shares":563608243,"eps":1.4785684735085327,"marketStatus":"Market Closed","change":-0.5,"latestTime":"04-24 16:08:27","open":105.3,"high":106.6,"low":100.8,"amount":304217995,"amplitude":0.055396,"askPrice":104.2,"askSize":5500,"bidPrice":104,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":1.4785684735085327,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":7,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":104.7,"openAndCloseTimeList":[[1776994200000,1777003200000],[1777006800000,1777017600000]],"volumeRatio":0.7986723718805605,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"Remegen Co.,Ltd.","latestPrice":133.03,"timestamp":1777014000000,"preClose":134.9,"halted":0,"volume":6486300,"delay":0,"premium":"-31.66"}},"requestUrl":"/m/hq/s/09995/wiki","defaultTab":"wiki","newsList":[{"id":"1105593446","title":"Biopharma Stocks Slide Across Board as Oil Prices Squeeze Rate Cut Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=1105593446","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105593446?lang=en_us&edition=fundamental","pubTime":"2026-04-23 14:02","pubTimestamp":1776924147,"startTime":"0","endTime":"0","summary":"Innovative drug stocks experienced broad declines in Hong Kong trading. At the time of writing, 3SBIO (01530) fell 12.73% to HK$21.38. REMEGEN (09995) dropped 6.86% to HK$105.9. INNOVENT BIO (01801)...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DIG","GUSH","159992","LU2097828714.EUR","BWET","DBC","BK1583","01530","DRIP","BK1593","OILU","UGA","BK4570","01801","DRLL","06978","LU2097828631.EUR","OIH","LU2328871848.SGD","03692","HK0000165453.HKD","LU2488822045.USD","USE","OILT","BNO","LU0455707207.USD","BK1191","OILK","BK1574","BK1161","LU2097828557.USD","LU2097828805.USD","09995","DBO","IXC","LU0502904849.HKD","DBE","BK4588","DUG","BK4585","ERX","VDE","USL","LU1969619763.USD","USOI","BK1589","LU2097828474.EUR","IEO","PXJ","VXUS","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165196464","title":"HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165196464","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165196464?lang=en_us&edition=fundamental","pubTime":"2026-04-23 11:32","pubTimestamp":1776915127,"startTime":"0","endTime":"0","summary":"HK biotech stocks fell. Akeso down 12%; Remegen, Zai Lab, KeyMed and Junshi down 7%; Lepu and Innocare down 6%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","01672","09688","09606","09995","06606","03347","02162","02268","02137","02359","03759","09926","06978","02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147793946","title":"Stock Track | REMEGEN Plummets 5.19% Intraday as Profit-Taking Follows Fully Priced-In Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1147793946","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147793946?lang=en_us&edition=fundamental","pubTime":"2026-04-23 09:45","pubTimestamp":1776908718,"startTime":"0","endTime":"0","summary":"REMEGEN's stock plummeted 5.19% intraday, extending a high-level correction as recent positive developments appear to have been fully absorbed by the market.The decline follows significant catalysts,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165371507","title":"Profitability Reaches 17 Biotech Firms Including BeiGene, Innovent, Beta Pharma, and Remegen","url":"https://stock-news.laohu8.com/highlight/detail?id=1165371507","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165371507?lang=en_us&edition=fundamental","pubTime":"2026-04-21 20:23","pubTimestamp":1776774222,"startTime":"0","endTime":"0","summary":"As earnings season arrives, China's innovative drug industry has delivered a more robust report card compared to previous years. According to incomplete statistics, at least 17 listed innovative...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","BK1161","09995","BK1574","BK4588","BK4581","LU2328871848.SGD","LU1064131003.USD","LU2148510915.USD","BK1583","BK0239","XBI","LU1969619763.USD","LU2488822045.USD","LU1064130708.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628737264","title":"Why RemeGen (SEHK:9995) Is Up 13.1% After First HER2 ADC–Immunotherapy Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2628737264","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628737264?lang=en_us&edition=fundamental","pubTime":"2026-04-18 15:04","pubTimestamp":1776495882,"startTime":"0","endTime":"0","summary":"RemeGen announced that China’s NMPA has approved a new indication for its antibody-drug conjugate Disitamab Vedotin, in combination with Toripalimab, to treat HER2-expressing locally advanced or metastatic urothelial carcinoma, marking the drug’s fifth approved use in China.\nThis approval is underpinned by a large Phase III trial showing the combo outperformed standard platinum-based chemotherapy across the full spectrum of HER2 expression, reinforcing the clinical relevance of pairing...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/why-remegen-sehk9995-is-up-131-after-first-her2-adcimmunothe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/why-remegen-sehk9995-is-up-131-after-first-her2-adcimmunothe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4231","AGIX","BK1583","LU1969619763.USD","BK4551","BK4588","AIPO","09995","BK4543","AIYY","BK4528","LU2328871848.SGD","BK1574","BK1161","CHAT","ADC","BK4080","AI","ARTY","BK4023","BK4587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174576271","title":"RemeGen Schedules 28 April 2026 Board Meeting to Review Q1 2026 Unaudited Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1174576271","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174576271?lang=en_us&edition=fundamental","pubTime":"2026-04-16 17:03","pubTimestamp":1776330231,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. announced that its board of directors will convene on 28 April 2026 to consider and approve the unaudited financial results for the three months ended 31 March 2026, along with the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153591250","title":"CATL Reports 48.52% Surge in Q1 Net Profit to RMB 20.74 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1153591250","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153591250?lang=en_us&edition=fundamental","pubTime":"2026-04-16 09:23","pubTimestamp":1776302616,"startTime":"0","endTime":"0","summary":"CATL (03750) plans to invest RMB 30 billion to establish a wholly-owned subsidiary for building a new energy mineral platform. Meig Smart Technology (03268) intends to invest RMB 300 million in an AI...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f2ca9b0f4a170b1d9ddb723b50e84ead","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0188438112.USD","LU1282648689.USD","LU1880383366.USD","SGXZ81163826.USD","MIUmain","03268","LU0327786744.USD","LU0228659784.USD","LU1961090484.USD","LU0117841782.USD","LU1880383440.USD","LU1323998911.USD","LU0345776255.USD","LU2294711713.HKD","LU1580142542.USD","LU0307460666.USD","LU0348816934.USD","LU2357125470.USD","SG9999001846.SGD","02556","LU0052750758.USD","LU2449936058.SGD","LU0251143458.SGD","LU0192582467.USD","LU0502904849.HKD","LU0572944931.SGD","LU0516423174.USD","LU0605514214.HKD","LU1152091168.USD","LU1960683339.HKD","LU0531971595.HKD","BK1521","LU2238339852.HKD","LU0067412154.USD","LU1808992512.USD","LU2153592121.USD","LU1655091616.SGD","LU0348814723.USD","IE00B8L5B284.USD","LU2298322129.HKD","BK4585","LU0700851271.USD","LU2580892862.HKD","LU0509642566.USD","LU0634319403.HKD","LU0651947912.USD","LU0140636845.USD","LU0505663152.USD","LU1152091754.HKD","IE00BZ199S13.USD","LU2328871848.SGD","01138","LU0043850808.USD","LU2257852520.SGD","BK1116","LU1188198961.HKD","LU2348773727.SGD","LU0516422440.USD","LU2087589342.USD","LU0501845795.SGD","LU0821914370.USD","LU2348774022.SGD","LU1146622755.USD","LU1303224171.USD","MIUmain","LU1997245177.USD","LU0456827905.SGD","LU1861219969.SGD","LU1807302812.USD","LU1008478684.HKD","300750","01810","LU2580892789.USD","LU0348805143.USD","LU2097828631.EUR","IE0032431581.USD","BK1149","LU0823397285.USD","BK1575","LU0651946864.USD","LU1102505762.USD","LU0359201885.HKD","LU0823040885.USD","LU0823426308.USD","LU0106252389.USD","LU0106259558.USD","SG9999001093.SGD","LU0797268264.HKD","LU0244354667.USD","LU0149534421.HKD","IE00BPRC5H50.USD","LU0348825331.USD","LU0370786039.SGD","LU0107464264.USD","601111","LU0211977185.USD","LU2125910500.SGD","IE0034224299.USD","LU2125910849.SGD","601995","LU1105468828.SGD","LU0164880469.USD","LU0823414551.USD","LU1251922891.USD","LU2424517915.HKD","LU1051768304.USD","LU0405327494.USD","002352","LU1242518931.SGD","LU0072913022.USD","LU0561508036.HKD","LU2242644610.SGD","SG9999014674.SGD","LU2399975544.HKD","LU0441854154.USD","SG9999002828.SGD","LU0049853897.USD","01177","LU0543330483.HKD","LU0011963245.USD","LU2039709279.SGD","BK1193","LU0918141887.USD","LU1048596156.SGD","LU0672654166.SGD","XIACY","LU2152927971.USD","LU2275660780.HKD","LU1956131251.USD","BK1523","LU0823041008.USD","LU0048575426.USD","LU1064131003.USD","BK4141","LU1102505929.USD","HK0000181138.USD","BK1535","LU0149721374.USD","SG9999000327.SGD","600115","LU2097828805.USD","LU0048388663.USD","SG9999003461.SGD","SBHMY","LU0359201612.USD","002881","01898","000333","LU2495084118.USD","BK1502","LU0880133367.SGD","BK0224","IE00B3M56506.USD","LU1770034418.SGD","EVS.SI","LU0708995583.HKD","LU0724618433.USD","LU0261950470.USD","BK1607","LU0348735423.USD","LU0823038988.USD","06656","HK0000181112.HKD","LU0254981946.USD","LU1979443071.USD","03750","LU2294711473.HKD","LU2476274720.SGD","00753","LU0164872284.USD","LU0588546209.SGD","HXXD.SI","LU0143863198.USD","LU0607220059.USD","LU1794554557.SGD","01093","300433","BK1610","LU2506952253.HKD","LU1969619763.USD","02038","IE00B29SXG58.USD","09995","SG9999001903.USD","LU2097828714.EUR","LU3063872942.SGD","LU2506952410.USD","LU0823413587.USD","SG9999002463.SGD","LU1769817179.HKD","LU1997245094.SGD","LU0611395673.USD","LU0449515922.USD","BK1506","LU0302445910.USD","LU0499858602.USD","LU2153591404.USD","IE0003795394.USD","LU2226246903.HKD","BK1615","LU1861214812.USD","LU1328277881.USD","LU2148510915.USD","LU0214875030.USD","LU0823414478.USD","LU0048580855.USD","LU0463099449.HKD","LU1769817096.USD","LU0531970944.HKD","00670","LU1515016050.SGD","688331","SGXZ49509284.SGD","IE00B5MMRT66.SGD","LU2249611893.SGD","600026","LU0516423091.SGD","LU2097828557.USD","LU2476274308.USD","LU0449509016.USD","LU0540923850.HKD","SG9999001689.USD","03908","LU0594300179.USD","IE00B543WZ88.USD","LU2506952337.HKD","LU0828237940.HKD","LU0320764755.SGD","LU0675040207.SGD","02298","LU0047713382.USD","08279","603906","02186","LU0106959298.USD","LU0164865239.USD","LU1868837565.USD","LU0469268626.HKD","LU1255011170.USD","BK1618","SG9999000459.SGD","LU0235996351.USD","LU0320764599.SGD","BK4519","LU0072462343.USD","LU1939255532.USD","LU0051755006.USD","LU2097828474.EUR","LU0210526637.USD","HK0000286598.CNH","LU1770036033.HKD","LU0823437842.USD","LU0314109678.HKD","LU1242518857.USD","LU0169518387.USD","CCOZY","LU1048588211.SGD","LU0455707207.USD","IE00B8HQ1Z84.USD","LU0417516738.SGD","02245","LU0823397103.USD","LU1064130708.USD","LU1934453819.USD","LU0594300419.USD","LU0650527681.SGD","LU1820825898.SGD","LU0979878070.USD","LU0054450605.USD","LU0417516902.SGD","LU1978683503.SGD","LU1868838027.USD","LU0345775950.USD","BK1589","LU1481107354.HKD","LU1721428347.USD","LU0269904917.USD","LU0029875118.USD","LU0326948709.USD","LU0871576103.HKD","LU1719994722.HKD","LU0084288322.USD","LU1039395188.USD","LU0823039010.USD","LU2778985437.USD","LU0823413660.USD","LU0823426480.USD","LU0499858438.USD","06613","LU0143863784.USD","LU0312595415.SGD","LU0128522157.USD","LU2506951792.HKD","LU0181495838.USD","FXCNY","06936","LU0828237510.HKD","LU1813983027.USD","LU0132412106.USD","LU0405327148.USD","LU1051769294.HKD","LU2289578879.USD","BK4526","LU0593848301.USD","02465","LU2298064838.USD","LU1023057109.AUD","LU1993786604.SGD","LU0259732245.USD","HK0000165453.HKD","LU0516422952.EUR","81810","LU0231483743.USD","LU1981816686.USD","LU1720050803.USD","LU1781817850.SGD","LU0516422366.SGD","LU0828238088.HKD","LU0326950275.SGD","BK1166","LU0348827113.USD","LU0456846285.SGD","LU0039217434.USD","LU0359202008.SGD","LU0328353924.USD","LU0124384867.USD","LU2360107325.USD","LU2045819591.USD","LU1831875114.USD","BK4588","00300","IE00BD6J9T35.USD","LU1997244956.HKD","LU0165289439.USD","LU2477742899.HKD","LU0918141705.HKD","601898","IE0003851619.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156350161","title":"National Data Administration Proposes Token Trading Exploration; Central Bank Adjusts Overseas Loan Ratios","url":"https://stock-news.laohu8.com/highlight/detail?id=1156350161","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156350161?lang=en_us&edition=fundamental","pubTime":"2026-04-16 07:49","pubTimestamp":1776296980,"startTime":"0","endTime":"0","summary":"The National Data Administration is seeking public feedback on an implementation plan for advancing the construction of high-quality industry datasets. The draft proposal suggests exploring...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1807302812.USD","BK1564","LU1152091754.HKD","LU1969619763.USD","BK1190","BK1516","08279","BK1501","688331","09995","SBHMY","BK1161","LU0359201885.HKD","LU1152091168.USD","BK4585","LU0067412154.USD","03750","BK1610","LU1960683339.HKD","01177","BK1574","BK1147","LU0359201612.USD","300750","LU0359202008.SGD","BK1583","LU1023057109.AUD","601995","02245","LU1008478684.HKD","LU2328871848.SGD","LU1993786604.SGD","06656","BK4588","LU0880133367.SGD","SG9999002828.SGD","03908","BK1116"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190335375","title":"Remegen Receives $650 Million Upfront Payment from AbbVie for RC148 Exclusive Licensing Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=1190335375","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190335375?lang=en_us&edition=fundamental","pubTime":"2026-04-15 16:48","pubTimestamp":1776242901,"startTime":"0","endTime":"0","summary":"Remegen (09995) announced that on January 12, 2026, the company entered into an exclusive licensing agreement with AbbVie for RC148, which took effect on March 10, 2026. Under the agreement, AbbVie...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2148510915.USD","LU2328871848.SGD","BK0239","09995","LU1064131003.USD","LU2488822045.USD","LU1064130708.USD","BK1583","LU1969619763.USD","688331","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141245169","title":"Stock Track | REMEGEN Soars 5.17% Intraday on New Drug Approval and Strong Earnings Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=1141245169","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141245169?lang=en_us&edition=fundamental","pubTime":"2026-04-15 10:25","pubTimestamp":1776219925,"startTime":"0","endTime":"0","summary":"REMEGEN's stock price surged 5.17% during intraday trading on Wednesday, reflecting strong positive momentum in the market.The significant rise follows the company's announcement that its core ADC...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627486993","title":"BUZZ-RemeGen set for best day in two weeks on China nod for tumour drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2627486993","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627486993?lang=en_us&edition=fundamental","pubTime":"2026-04-13 12:15","pubTimestamp":1776053702,"startTime":"0","endTime":"0","summary":"BUZZ-RemeGen set for best day in two weeks on China nod for tumour drug application    ** Shanghai-listed shares of RemeGen Co Ltd 688331.SS jump 6.7% to 144.53 yuan, on course to snap five straight sessions of declines and heading for the biggest one-day pct rise since April 1 if current gains hold     ** Hong Kong shares of RemeGen 9995.HK surge 5.2% to HK$111.5, on track to snap three consecutive sessions of declines and set for the biggest one-day pct gain since April 1** China-based biopharmaceutical research and production group says it has received \"drug registration certificate\" approved and issued by China's National Medical Products Administration  for Disitamab Vedotin ** Disitamab Vedotin is for treatment of HER2-expressing urothelial carcinoma, one of the most common malignant tumour globally - Co ** YTD, Shanghai-listed shares up 84.7%, Hong Kong stock up 51.8%   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL1N40W031:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","LU2148510915.USD","BK1583","BK1161","688331","BK1574","LU2328871848.SGD","BK0239","LU2488822045.USD","LU1064131003.USD","09995","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627548329","title":"RemeGen Drug Approved For Cancer Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2627548329","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627548329?lang=en_us&edition=fundamental","pubTime":"2026-04-13 11:02","pubTimestamp":1776049365,"startTime":"0","endTime":"0","summary":"RemeGen  said China's drug regulator approved its Disitamab Vedotin for the treatment of a type of bladder cancer, according to a Hong Kong bourse filing Friday.Shares of the firm gained over 4% in morning trade Monday.The drug was approved in combination with toripalimab for the treatment of urothelial carcinoma which expresses the HER2 protein.The approval marks the fifth indication for Disitamab Vedotin in China.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","09995","LU2328871848.SGD","BK1583","BK1161","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140166703","title":"Stock Track | REMEGEN Soars 5.09% Intraday on New Drug Approval and Strong Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1140166703","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140166703?lang=en_us&edition=fundamental","pubTime":"2026-04-13 09:57","pubTimestamp":1776045452,"startTime":"0","endTime":"0","summary":"REMEGEN's stock surged 5.09% during intraday trading on Monday, reflecting positive market reaction to significant company developments.The biopharmaceutical company announced that the New Drug...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133477900","title":"Hong Kong Grants First Stablecoin Issuer Licenses as Iran-US Talks Show Major Rifts","url":"https://stock-news.laohu8.com/highlight/detail?id=1133477900","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133477900?lang=en_us&edition=fundamental","pubTime":"2026-04-13 07:38","pubTimestamp":1776037093,"startTime":"0","endTime":"0","summary":"Hong Kong's monetary authority has issued the city's first stablecoin issuer licenses. The Hong Kong Monetary Authority announced on April 10 that, pursuant to the Stablecoin Ordinance, the Monetary...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"9ce234e975b339d1ff0dccd1ea6913c1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06680","LU2328871848.SGD","CRCD","LUMN","03317","BK1228","LU1861558580.USD","CRCO","06166","LU1861220207.SGD","06960","BK1556","BK1596","LU1969619763.USD","CCUP","LU1861217088.USD","603083","C","BK1574","01773","06869","LU1791807156.HKD","BK1161","300748","LU1861559042.SGD","AVGO","LU2360107671.USD","06088","BK1583","LU0106831901.USD","06185","AMD","CRCA","CRCG","688185","AMZN","BK4023","BK4585","09995","BK4588","ICRC","601869","LU1668664300.SGD","HSBC","WFC","BK1500","688331","NVDA","01729","BAC","00005"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152557389","title":"RemeGen receives NMPA approval for Disitamab Vedotin + Toripalimab in HER2-expressing urothelial carcinoma, securing fifth on-label use","url":"https://stock-news.laohu8.com/highlight/detail?id=1152557389","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152557389?lang=en_us&edition=fundamental","pubTime":"2026-04-10 22:42","pubTimestamp":1775832176,"startTime":"0","endTime":"0","summary":"RemeGen announced that China’s National Medical Products Administration has issued a Drug Registration Certificate permitting Disitamab Vedotin (RC48, trade name: 愛地希®) in combination with...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119892217","title":"RemeGen Maintains 564.48 Million Share Capital; Confirms Public Float Compliance for March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1119892217","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119892217?lang=en_us&edition=fundamental","pubTime":"2026-04-09 16:40","pubTimestamp":1775724032,"startTime":"0","endTime":"0","summary":"RemeGen Co., Ltd. released its Monthly Return for the period ended 31 March 2026, indicating no changes to either authorised/registered or issued share capital across its dual-listed share classes....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624169823","title":"RemeGen (HKG:9995) Is Posting Healthy Earnings, But It Is Not All Good News","url":"https://stock-news.laohu8.com/highlight/detail?id=2624169823","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624169823?lang=en_us&edition=fundamental","pubTime":"2026-04-04 06:42","pubTimestamp":1775256139,"startTime":"0","endTime":"0","summary":"After announcing healthy earnings, RemeGen Co., Ltd.'s ( HKG:9995 ) stock rose over the last week. Despite the strong...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-hkg9995-is-posting-healthy-earnings-but-it-is-not-al","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9995/remegen-shares/news/remegen-hkg9995-is-posting-healthy-earnings-but-it-is-not-al","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172541363","title":"China International Capital Corp. Highlights Positive Trends in Domestic Innovative Drug Sector, Anticipates Key Academic Developments in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1172541363","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172541363?lang=en_us&edition=fundamental","pubTime":"2026-04-03 10:54","pubTimestamp":1775184869,"startTime":"0","endTime":"0","summary":"According to statistics from the NMPA and PharmaGO, the total business development value for domestic innovative drugs in the first quarter of 2026 exceeded $60 billion, surpassing the full-year 2024...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348827113.USD","LU2328871848.SGD","LU1720050803.USD","LU0348784397.USD","LU0359202008.SGD","IE00B543WZ88.USD","LU0348735423.USD","LU0540923850.HKD","BK1161","LU0359201885.HKD","LU0348783233.USD","IE00B5MMRT66.SGD","BK1583","LU0417516571.SGD","LU2399975544.HKD","LU0348825331.USD","BK1588","LU2476274720.SGD","LU0359201612.USD","LU0588546209.SGD","BK1515","LU1719994722.HKD","09995","09926","BK1500","LU1961090484.USD","LU2543165471.USD","LU0417516902.SGD","LU2488822045.USD","LU0417516738.SGD","IE00BPRC5H50.USD","LU0561508036.HKD","LU1251922891.USD","LU1770034418.SGD","BK1191","LU1794554557.SGD","LU1303224171.USD","06978","LU1023057109.AUD","LU2476274308.USD","LU2778985437.USD","LU0348767384.USD","06938","LU0348766576.USD","01877","LU1969619763.USD","LU0307460666.USD","159992","06160","01276","BK1574","LU0634319403.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140369492","title":"China International Capital Corporation Maintains Outperform Rating on REMEGEN, Raises Target Price to HK$133.7","url":"https://stock-news.laohu8.com/highlight/detail?id=1140369492","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140369492?lang=en_us&edition=fundamental","pubTime":"2026-04-03 10:52","pubTimestamp":1775184759,"startTime":"0","endTime":"0","summary":"China International Capital Corporation (CICC) has released a research report reiterating its Outperform rating on REMEGEN (09995) and increasing its target price by 26.8% to HK$133.7. This new...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","EWH","LU2148510915.USD","09995","LU2328871848.SGD","LU2488822045.USD","LU1064130708.USD","LU1064131003.USD","688331","BK0239","BK1161","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178735170","title":"Lilly's Oral GLP-1 Weight Loss Drug Receives FDA Approval, Offering Daily Pill Alternative to Injections","url":"https://stock-news.laohu8.com/highlight/detail?id=1178735170","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178735170?lang=en_us&edition=fundamental","pubTime":"2026-04-03 10:45","pubTimestamp":1775184311,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration (FDA) approved Eli Lilly's oral GLP-1 drug, Foundayo (active ingredient: orforglipron), for market release this Wednesday. This marks a significant milestone for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","LU0823434740.USD","IE00BJJMRX11.SGD","LU2237443549.SGD","IE00BN29S564.USD","LU2168564149.EUR","LU0882574139.USD","BK4516","LU0354030511.USD","LU2087625088.SGD","LU2236285917.USD","SG9999015952.SGD","BK4599","LU0289739699.SGD","SG9999013999.USD","LU0234572021.USD","LU0820562030.AUD","LU1988902786.USD","LU2360106947.USD","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU2213496289.HKD","LU2462157665.USD","LU0689472784.USD","LU0353189763.USD","LU2106854487.HKD","LU2491050154.USD","IE0002141913.USD","IE00BK4W5L77.USD","BK4581","LU1069344957.HKD","LU0058720904.USD","LU0823434583.USD","LU1023059063.AUD","IE0004445239.USD","LU1267930730.SGD","LU1629891620.HKD","SGXZ51526630.SGD","BK4534","LU0964807845.USD","IE00BKPKM429.USD","LU0122379950.USD","LU0316494557.USD","LU2361045086.USD","LU1551013425.SGD","LU0417517546.SGD","LU0079474960.USD","LU2028103732.USD","LU2168563687.JPY","LU0820561909.HKD","LU2471134952.CNY","LU2746668974.SGD","LU0456855351.SGD","SG9999001176.USD","LU2471134796.USD","LU1280957306.USD","LU2552382058.USD","LU0354030438.USD","LU2023250504.SGD","LU2361044865.SGD","LU0198837287.USD","IE00B1XK9C88.USD","LU0238689110.USD","LU0256863811.USD","LU0683600562.USD","LU1917777945.USD","IE00B1BXHZ80.USD","LU2023251221.USD","LU2237438978.USD","09995","LU1127390331.HKD","LU0471298694.HKD","LU0203202063.USD","SG9999015945.SGD","LU1868836591.USD","SG9999014880.SGD","SG9999018857.SGD","IE00BFSS8Q28.SGD","LU0672654240.SGD","LU1868837300.USD","LU0943347566.SGD","LU0203201768.USD","LU2750360997.AUD","LU2602419157.SGD","LU2168564495.EUR","LU0061475181.USD","LU1291159041.SGD","IE00BJT1NW94.SGD","LU2357305700.SGD","LU2211815571.USD","LU0823416689.USD","LU1712237335.SGD","LU2237443895.HKD","IE00BJLML261.HKD","LU0323591593.USD","IE00B775H168.HKD","LU1868836757.USD","LU1323610961.USD","LU2750360641.GBP","IE00BFSS7M15.SGD","LLYX","LLYZ","LU0106261372.USD","LU2089283258.USD","LU0432979614.USD","LU1232071149.USD","LU2552382132.HKD","LU2111349929.HKD","LU2168564065.EUR","IE00BKDWB100.SGD","BK4585","LU2746668461.USD","LU0097036916.USD","SHWGY","LU1623119135.USD","SG9999015978.USD","LU1804176565.USD","LU0471298777.SGD","LU0385154629.USD","LU0225283273.USD","LU2471134879.HKD","IE00B4R5TH58.HKD","IE00B7KXQ091.USD","IE00BK4W5M84.HKD","LU1551013342.USD","LU0353189680.USD","SG9999001176.SGD","LU1035775433.USD","LU1366192091.USD","LU2491049909.HKD","LU2108987350.USD","LU0786609619.USD","LU1868836914.USD","LU2468319806.SGD","01066","LU2456880835.USD","LU2361044949.HKD","688331","LU2756315318.SGD","LU0320765059.SGD","LU0820561818.USD","LU2491050071.SGD","LU2063271972.USD","LU2237443978.SGD","IE00BJJMRY28.SGD","LU1720051017.SGD","LU2264538146.SGD","ELIL","LU0158827948.USD","BK4007","LU2112291526.USD","LU2756315664.SGD","LU2023250330.USD","LU2896262040.SGD","LU1064131342.USD","SG9999014898.SGD","LLII","LU0094547139.USD","LU1057294990.SGD","SG9999015986.USD","LU0006306889.USD","LU2089984988.USD","SG9999014914.USD","SGXZ81514606.USD","LU0320765992.SGD","LU1983299246.USD","IE00B4JS1V06.HKD","LU0096364046.USD","LU0114720955.EUR","LU2461242641.AUD","IE0001KFT4U8.USD","IE00B2B36J28.USD","SG9999017495.SGD","LU0109391861.USD","LU2237443465.HKD","IE00BWXC8680.SGD","LU2552382215.SGD","LU0882574055.USD","LU1720051108.HKD","LU1814569148.SGD","LU2271345857.HKD","SG9999018865.SGD","BK4588","LU2237443382.USD","LU2237443622.USD","IE0004445015.USD","LU2324357040.USD","LU0466842654.USD","LU1093756168.USD","LU0109394709.USD","LU1548497426.USD","SGXZ31699556.SGD","LU1989771016.USD","LU1974910355.USD","LU0640476718.USD","BK4533","SGXZ57979304.SGD","LLY","LU2089284900.SGD","LU2417539215.USD","SGXZ99366536.SGD","SG9999014906.USD","IE0005OL40V9.USD","GB00BDT5M118.USD","LU2168564222.USD","LU0158827781.USD","LU0708995401.HKD","LU0210536198.USD","LU2471134523.USD","LU1868837136.USD","IE00BFTCPJ56.SGD","ELIS","LU1061106388.HKD","IE0009355771.USD","LU2265009873.SGD","LU0787776722.HKD","LU1145028129.USD","LU0256863902.USD","LU0266013472.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1309},{"period":"1month","weight":0.1369},{"period":"3month","weight":0.1552},{"period":"6month","weight":0.2324},{"period":"1year","weight":1.52},{"period":"ytd","weight":0.4472}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0.0253},{"period":"3month","weight":-0.0288},{"period":"6month","weight":-0.007},{"period":"1year","weight":0.1857},{"period":"ytd","weight":0.0136}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"RemeGen Co Ltd is a China-based company principally engaged in biopharmaceutical research, biopharmaceutical service, biopharmaceutical production and sale. The Company focuses on therapeutic antibody drugs such as antibody-drug conjugates (ADC), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company’s main products include telitacicept, disitamab vedotin, RC28-E and others. The Company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The Company mainly operates its businesses in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.167223},{"month":3,"riseRate":0.5,"avgChangeRate":0.012545},{"month":4,"riseRate":0.833333,"avgChangeRate":0.101531},{"month":5,"riseRate":0.4,"avgChangeRate":-0.023394},{"month":6,"riseRate":0.8,"avgChangeRate":0.127757},{"month":7,"riseRate":0.6,"avgChangeRate":-0.032319},{"month":8,"riseRate":0.4,"avgChangeRate":0.068611},{"month":9,"riseRate":0.6,"avgChangeRate":0.099222},{"month":10,"riseRate":0.4,"avgChangeRate":0.027845},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"REMEGEN","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"REMEGEN,09995,REMEGEN股票,REMEGEN股票老虎,REMEGEN股票老虎国际,REMEGEN行情,REMEGEN股票行情,REMEGEN股价,REMEGEN股市,REMEGEN股票价格,REMEGEN股票交易,REMEGEN股票购买,REMEGEN股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"REMEGEN(09995),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest REMEGEN(09995) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}